Veterinary Medicine International

Veterinary Medicine International / 2014 / Article

Erratum | Open Access

Volume 2014 |Article ID 390875 | 2 pages | https://doi.org/10.1155/2014/390875

Erratum to “Comparative Pharmacokinetics of Levofloxacin in Healthy and Renal Damaged Muscovy Ducks following Intravenous and Oral Administration”

Received23 Feb 2014
Accepted02 Mar 2014
Published16 Mar 2014

The following errors occurred in Table 2 and Page 4.


ParameterUnitHealthyRenal damaged

h−1
h−1
h
h
g mL−1
h
AUC g mL−1h−1
AUMC g mL−1h−2
MRTh
MATh
F %
/MICRatio
AUC/MICRatio

, refers to degree of significance.
: first-order absorption rate constant; : elimination rate constant; : absorption half-life; : elimination half-life; : maximum plasma concentration; : time to peak plasma concentration; MAT: mean absorption time; F: fraction of drug absorbed systemically after PO administration; /MIC: maximum serum concentration/minimum inhibitory concentration ratio; AUC/MIC: area under concentration-time curve/MIC ratio.

AUMC value in healthy ducks is 73.46 μg mL−1 h−2 instead of 37.46 μg mL−1 h−2.

MAT value in healthy ducks is 0.74 h instead of 0.31 h and MAT value in renal damaged ducks is 0.70 h instead of 2.08 h, with no significance in MAT between healthy and renal damaged ducks.

In Page 4, last line in left column, low MAT (mean absorption time) value is 0.74 h instead of 0.31 h.

Copyright © 2014 Mohamed Aboubakr and Ahmed Soliman. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

572 Views | 413 Downloads | 1 Citation
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.